Stevens-Johnson Syndrome Latest Advances

The Role of the Boston Keratoprosthesis in Severe Ocular Surface Disease and Autoimmune Diseases.

Journal: Seminars in ophthalmology

Published: January 19, 2026

A case of Stevens-Johnson syndrome triggered by Mycoplasma infection.

Journal: Journal of oral science

Published: January 18, 2026

A Case of Toxic Epidermal Necrolysis during Chemotherapy for Advanced Gastric Cancer

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Microbiological findings and antimicrobial resistance dynamics in pathogens isolated from patients with toxic epidermal necrolysis: a single center experience.

Journal: Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne

Published: January 15, 2026

Validation of International Classification of Diseases Codes for Dermatologic Conditions: A Systematic Review.

Journal: JAMA dermatology

Published: January 07, 2026

Delayed presentation of pembrolizumab-induced SJS-TEN overlap syndrome.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 19, 2025

Cheilitis: a comprehensive review and a new clinical classification proposal. Part 1: Isolated cheilitis.

Journal: Italian journal of dermatology and venereology

Published: December 18, 2025

An Atypical Trigger of Stevens-Johnson Syndrome with Severe Ocular Complications.

Journal: Irish medical journal

Published: December 11, 2025

Incidence and clinical patterns, severity and preventability of cutaneous adverse drug reactions among hospitalized patients in a tertiary centre.

Journal: The Medical journal of Malaysia

Published: December 02, 2025

Cheilitis: a comprehensive review and a new clinical classification proposal. Part 2: Cheilitis associated with dermatological diseases, systemic diseases, or drug reactions.

Journal: Italian journal of dermatology and venereology

Published: December 02, 2025

Guidelines for the Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis 2025 Supplement.

Journal: The Journal of dermatology

Published: November 30, 2025

Analysis of clinical characteristics of tislelizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Chinese population: a systematic review.

Journal: Cutaneous and ocular toxicology

Published: November 21, 2025